Mental Health and Physical Activity in Women with Polycystic Ovary Syndrome: A Brief Review

Sports Medicine

Volumn 45, Issue 4, 2015, Pages 497-504

  Conte, Francesca ^a,b   Banting, Lauren ^a   Teede, Helena J ^c,d   Stepto, Nigel K ^a,c  

^a VICTORIA UNIVERSITY   (Australia)

^b UNIVERSITY OF PADOVA   (Italy)

^c MONASH UNIVERSITY   (Australia)

^d SOUTHERN HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIETY; COMPLICATION; DEPRESSION; FEMALE; HUMAN; KINESIOTHERAPY; LOW CALORY DIET; MOTOR ACTIVITY; OBESITY; PHYSIOLOGY; POLYCYSTIC OVARY SYNDROME; PREVENTION AND CONTROL; PSYCHOLOGY; QUALITY OF LIFE;

ANXIETY; DEPRESSION; DIET, REDUCING; EXERCISE THERAPY; FEMALE; HUMANS; MOTOR ACTIVITY; OBESITY; POLYCYSTIC OVARY SYNDROME; QUALITY OF LIFE;

EID: 84939998840     PISSN: 01121642     EISSN: 11792035     Source Type: Journal    
DOI: 10.1007/s40279-014-0291-6     Document Type: Review

References (62)

1. Asuncion M, Calvo R, SanMillan J, et al. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab. 2000;85:2434–8.
2. Azziz R, Carmina E, Dewailly D, et al. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab. 2006;91:4237–45.
3. Gabrielli L, Aquino EM. Polycystic ovary syndrome in Salvador, Brazil: a prevalence study in primary healthcare. Reprod Biol Endocrinol. 2012;10:96.
4. Li R, Zhang Q, Yang D, et al. Prevalence of polycystic ovary syndrome in women in China: a large community-based study. Hum Reprod. 2013;28:2562–9.
5. March WA, Moore VM, Wilson KJ, et al. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod. 2010;25:544–51.
6. Yildiz BO, Bozdag G, Yapici Z, et al. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Hum Reprod. 2012;27:3067–73.
7. Boyle JA, Cunningham J, O’Dea K, et al. Prevalence of polycystic ovary syndrome in a sample of Indigenous women in Darwin. Australia Med J Aust. 2012;196:62–6.
8. Goodarzi MO, Quiñones MJ, Azziz R, et al. Polycystic ovary syndrome in Mexican–Americans: prevalence and association with the severity of insulin resistance. Fertil Steril. 2005;84:766–9.
9. Teede HJ, Joham AE, Paul E, et al. Longitudinal weight gain in women identified with polycystic ovary syndrome: results of an observational study in young women. Obesity. 2013;21:1526–32.
10. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81:19–25.
11. Dokras A. Cardiovascular disease risk factors in polycystic ovary syndrome. Semin Reprod Med. 2008;26:39–44.
12. Cussons AJ, Watts GF, Burke V, et al. Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome. Hum Reprod. 2008;23:2352–8.
13. Moran LJ, Ranasinha S, Zoungas S, et al. The contribution of diet, physical activity and sedentary behaviour to body mass index in women with and without polycystic ovary syndrome. Hum Reprod. 2013;28:2276–83.
14. Moran LJ, Strauss BJ, Teede HJ. Diabetes risk score in the diagnostic categories of polycystic ovary syndrome. Fertil Steril. 2011;95:1742–8.
15. Stepto NK, Cassar S, Joham AE, et al. Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic–hyperinsulaemic clamp. Hum Reprod. 2013;28:777–84.
16. Barnard L, Ferriday D, Guenther N, et al. Quality of life and psychological well being in polycystic ovary syndrome. Hum Reprod. 2007;22:2279–86.
17. Hahn S, Janssen OE, Tan S, et al. Clinical and psychological correlates of quality-of-life in polycystic ovary syndrome. Eur J Endocrinol. 2005;153:853–60.
18. Li Y, Li Y, Yu Ng EH, et al. Polycystic ovary syndrome is associated with negatively variable impacts on domains of health-related quality of life: evidence from a meta-analysis. Fertil Steril. 2011;96:452–8.
19. Deeks AA, Gibson-Helm ME, Paul E, et al. Is having polycystic ovary syndrome a predictor of poor psychological function including anxiety and depression? Hum Reprod. 2011 [Epub 2011/03/26].
20. Cinar N, Kizilarslanoglu MC, Harmanci A, et al. Depression, anxiety and cardiometabolic risk in polycystic ovary syndrome. Hum Reprod. 2011;26:3339–45.
21. Bazarganipour F, Ziaei S, Montazeri A, et al. Psychological investigation in patients with polycystic ovary syndrome. Health Qual Life Outcomes. 2013;11:141.
22. Benson S, Hahn S, Tan S, et al. Prevalence and implications of anxiety in polycystic ovary syndrome: results of an internet-based survey in Germany. Hum Reprod. 2009;24:1446–51.
23. Laggari V, Diareme S, Christogiorgos S, et al. Anxiety and depression in adolescents with polycystic ovary syndrome and Mayer–Rokitansky–Küster–Hauser syndrome. J Psychosom Obstet Gynaecol. 2009;30:83–8.
24. Barry J, Kuczmierczyk A, Hardiman PJ. Anxiety and depression in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2011;26:2442–51.
25. Coffey S, Bano G, Mason HD. Health-related quality of life in women with polycystic ovary syndrome: a comparison with the general population using the Polycystic Ovary Syndrome Questionnaire (PCOSQ) and the Short Form-36 (SF-36). Gynecol Endocrinol. 2006;22(2):80–6.
26. Cronin L, Guyatt G, Griffith L, et al. Development of a health-related quality-of-life questionnaire (PCOSQ) for women with polycystic ovary syndrome (PCOS). J Clin Endocrinol Metab. 1998;83:1976–87.
27. Eggers S, Kirchegast S. The Polycystic Ovary Syndrome—a medical condition but also an important psychosocial problem. Coll Antropol. 2001;25:673–85.
28. Stunkard AJ, Faith MS, Allison KC. Depression and obesity. Biol Psychiatry. 2003;54(3):330–7.
29. Ramezanzadeh F, Aghssa MM, Abedinia N, et al. A survey of relationship between anxiety, depression and duration of infertility. BMC Womens Health. 2004;4(1):9.
30. Sonino N, Fava GA, Mani E, et al. Quality of life of hirsute women. Postgrad Med J. 1993;69:186–9.
31. Davis SR, Tran J. Testosterone influences libido and well being in women. Trends Endocrinol Metab. 2001;12(1):33–7.
32. Silveira H, Moraes H, Oliveira N, et al. Physical exercise and clinically depressed patients: a systematic review and meta-analysis. Neuropsychobiology. 2013;67(2):61–8.
33. Pucci GC, Rech CR, Fermino RC, et al. Association between physical activity and quality of life in adults. Rev Saude Publica. 2012;46:166–79.
34. Fong DY, Ho JW, Hui BP, et al. Physical activity for cancer survivors: meta-analysis of randomised controlled trials. BMJ. 2012;30:e70.
35. Thomson RL, Buckley JD, Brinkworth GD. Exercise for the treatment and management of overweight women with polycystic ovary syndrome: a review of the literature. Obes Rev. 2011;12(5):e202–10.
36. Hutchison SK, Stepto NK, Harrison CL, et al. Effects of exercise on insulin resistance and body composition in overweight and obese women with and without polycystic ovary syndrome. J Clin Endocrinol Metab. 2011;96(1):E48–56. doi:10.1210/jc.2010-0828.
37. Thomson RL, Buckley JD, Lim SS, et al. Lifestyle management improves quality of life and depression in overweight and obese women with polycystic ovary syndrome. Fertil Steril. 2010;94(5):1812–6.
38. Stener-Victorin E, Holm G, Janson PO, et al. Acupuncture and physical exercise for affective symptoms and health-related quality of life in polycystic ovary syndrome: secondary analysis from a randomized controlled trial. BMC Complement Altern Med. 2013;13:131.
39. Nidhi R, Padmalatha V, Nagarathna R, et al. Effect of holistic yoga program on anxiety symptoms in adolescent girls with polycystic ovarian syndrome: a randomized control trial. Int J Yoga. 2012;5:112–7.
40. Galletly C, Moran L, Noakes M, et al. Psychological benefits of a high-protein, low-carbohydrate diet in obese women with polycystic ovary syndrome—a pilot study. Appetite. 2007;49:590–3.
41. Ladson G, Dodson WC, Sweet SD, et al. Effects of metformin in adolescents with polycystic ovary syndrome undertaking lifestyle therapy: a pilot randomized double-blind study. Fertil Steril. 2011;95:2595–8.
42. Ladson G, Dodson WC, Sweet SD, et al. The effects of metformin with lifestyle therapy in polycystic ovary syndrome: a randomized double-blind study. Fertil Steril. 2011;95:1059–66.e1–7.
43. Harris-Glocker M, Davidson K, Kochman L, et al. Improvement in quality-of-life questionnaire measures in obese adolescent females with polycystic ovary syndrome treated with lifestyle changes and oral contraceptives, with or without metformin. Fertil Steril. 2010;93(3):1016–9.
44. Lamb JD, Johnstone EB, Rousseau J-A, et al. Physical activity in women with polycystic ovary syndrome: prevalence, predictors, and positive health associations. Am J Obstet Gynecol. 2011;204(4):352.e1–6.
45. Stephens T. Physical activity and mental health in the United States and Canada: evidence from four population surveys. Prev Med. 1988;17(1):35–47. doi:10.1016/0091-7435(88)90070-9.
46. Kirk AF, Higgins LA, Hughes AR, et al. A randomized, controlled trial to study the effect of exercise consultation on the promotion of physical activity in people with type 2 diabetes: a pilot study. Diabet Med. 2001;18(11):877–82. doi:10.1046/j.0742-3071.2001.00570.x.
47. Rippe JM, Price JM, Hess SA, et al. Improved psychological well-being, quality of life, and health practices in moderately overweight women participating in a 12-week structured weight loss program. Obes Res. 1998;6(3):208–18. doi:10.1002/j.1550-8528.1998.tb00339.x.
48. Moran LJ, Hutchison SK, Norman RJ, et al. Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Syst Rev. 2011;16(2):CD007506. doi:10.1002/14651858.CD007506.pub2.
49. Banting LK, Gibson-Helm ME, Polman RE, et al. Physical activity and mental health in women with polycystic ovary syndrome. BMC Womens Health. 2014;14(1):51. doi:10.1186/1472-6874-14-51.
50. Lass N, Kleber M, Winkel K, et al. Effect of lifestyle intervention on features of polycystic ovarian syndrome, metabolic syndrome, and intima-media thickness in obese adolescent girls. J Clin Endocrinol Metab. 2011;96:3533–40.
51. Teede HJ, Misso ML, Deeks AA, et al. Guideline Development Groups. Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline. Med J Aust. 2011;195:S65–112.
52. Wild RA, Carmina E, Diamanti-Kandarakis E, et al. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J Clin Endocrinol Metab. 2010;95:2038–49.
53. Harrison CL, Stepto NK, Hutchison SK, et al. The impact of intensified exercise training on insulin resistance and fitness in overweight and obese women with and without polycystic ovary syndrome. Clin Endocrinol. 2012;76:351–7.
54. Curi DD, Fonseca AM, Marcondes JA, et al. Metformin versus lifestyle changes in treating women with polycystic ovary syndrome. Gynecol Endocrinol. 2012;28:182–5.
55. Thomson RL, Brinkworth GD, Noakes M, et al. The effect of diet and exercise on markers of endothelial function in overweight and obese women with polycystic ovary syndrome. Hum Reprod. 2012;27:2169–76.
56. Liao LM, Nesic J, Chadwick PM, et al. Exercise and body image distress in overweight and obese women with polycystic ovary syndrome: a pilot investigation. Gynecol Endocrinol. 2008;24(10):555–61.
57. Palomba S, Giallauria F, Falbo A, et al. Structured exercise training programme versus hypocaloric hyperproteic diet in obese polycystic ovary syndrome patients with anovulatory infertility: a 24-week pilot study. Hum Reprod. 2008;23:642–50.
58. Huber-Buchholz MM, Carey DG, Norman RJ. Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone. J Clin Endocrinol Metab. 1999;84:1470–4.
59. Ware JEJ, Sherbourne CD. The MOS 36-Item Short-Form. Health Survey (SF-36): I. Conceptual framework and item selection. Med Care. 1992;30(6):473–83.
60. Jones GL, Benes K, Clark TL, et al. The Polycystic Ovary Syndrome Health-Related Quality of Life Questionnaire (PCOSQ): a validation. Hum Reprod. 2004;19(2):371–7. doi:10.1093/humrep/deh048.
61. Jones GL, Hall JM, Balen AH, et al. Health-related quality of life measurement in women with polycystic ovary syndrome: a systematic review. Hum Reprod Update. 2008;14(1):15–25. doi:10.1093/humupd/dmm030.
62. Jones GL, Hall JM, Lashen HL, et al. Health-related quality of life among adolescents with polycystic ovary syndrome. Obstet Gynecol Neonatal Nurs. 2011;40(5):577–88. doi:10.1111/j.1552-6909.2011.01279.x.